February 5, 2005
Eli Lilly and Co. is the target of another proposed Zyprexa class action lawsuit in Canada.
The Zyprexa lawsuit is similar to another Canadian lawsuit filed last month. The Indianapolis, Indiana based drugmaker is being sued for damages of $900 million on behalf of all Canadians who took Zyprexa and became diabetic.
Zyprexa is approved as a schizophrenia and bipolar disorder drug and is Lilly’s best selling drug. The company also faces Zyprexa related lawsuits in the United States.
For more information on Zyprexa side effects and lawsuit information, please contact us.
More Recent Defective Drug News

